Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners Paris, France, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced...

InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones Oversubscribed $42 Million Series B Financing Provides Significant Runway to Support Continued Advancement of Innovative Inhaled Cardiovascular Therapy First Patients Dosed in Phase 2 Clinical Trial...